Genomes.io
PrivateLast Round
Strategic
Jun 18, 2025
Est. Valuation
$8.36M
Total Funding Raised
$21.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomes.io operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in June 2024.
Genomes.io is a biotechnology company that provides a private and secure DNA data bank allowing users to control and monetize their genomic data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Data Protection, Blockchain Infrastructure, Precision Medicine, Decentralized Storage
Business Model
B2B2C
Customer Profile
Data as a Service, Usage-Based SaaS, Services & Consulting, Hardware Sales
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomes.io Comparables
Compare Genomes.io with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenoBank.io | 88% | |
| Shivom | 80% | |
| IndyGeneUS Bio | 80% |
For institutional investors. Book with your work email.
Genomes.io Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 18, 2025 | ||||
| VC Round | Jun 12, 2024 | ||||
| Strategic | Aug 21, 2023 | ||||
| Crowdfunding | Mar 14, 2023 | ||||
| Crowdfunding | Jan 30, 2020 | ||||
Crowdfunding | Sep 30, 2019 |
For institutional investors. Book with your work email.
Genomes.io Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consensys Mesh | Accelerator |
| Modular Capital | VC Round |
| GEM Digital Limited | Strategic |
| Pantera Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 58% MoM, reaching 9.2K.
- Apr 18, 2026
Monthly visitors grew 79% MoM, reaching 3.4K.
For institutional investors. Book with your work email.
Genomes.io Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomes.io's valuation, stock price, and market status.
Is Genomes.io a public or private company?
Genomes.io is a private company.
What is the current stock price of Genomes.io?
Genomes.io is a private company, so its shares have no public market price. Caplight tracks Genomes.io's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomes.io worth (valuation)?
Genomes.io's valuation is estimated at $8.4M based on funding round data.
Can I buy Genomes.io stock?
Genomes.io shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomes.io's last funding round?
Genomes.io's most recent funding round was Strategic on June 18, 2025.
Who are the main investors in Genomes.io?
Key investors in Genomes.io include Modular Capital, Pantera Capital.
Will Genomes.io IPO soon?
No public IPO plans have been announced for Genomes.io.
How can I track Genomes.io secondary market activity?
Caplight tracks bids, offers, and trades in Genomes.io's shares on secondary markets.